Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Heme Oxygenase (HO) Activity and Adenosine Induced Vasodilation

NCT00856817 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT00856817
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00856817 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Heme Oxygenase (HO) Activity and Adenosine Induced Vasodilation
Lead sponsor
Radboud University Medical Center
Phase
Phase 4
Overall status
Terminated
Start date
March 31, 2009
Completion date
Not reported
Enrollment
6 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerotic cardiovascular disease